YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy
Introduction: YouTube is an unregulated platform that patients are using to learn about treatment options. Aim: To assess the reliability of YouTube videos (YTVs) related to male hypogonadism and testosterone therapy. Methods: Searching on YouTube by relevance and view count, we analyzed the top 10...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2021-04-01
|
Series: | Sexual Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2050116121000040 |
_version_ | 1797761207456759808 |
---|---|
author | Christopher J. Warren, BA John Wisener, BS Brittany Ward, BS Sara Behbahani, MS Tejash Shah, MD Adam Fano, BS Boris Paskhover, MD Hossein Sadeghi-Nejad, MD |
author_facet | Christopher J. Warren, BA John Wisener, BS Brittany Ward, BS Sara Behbahani, MS Tejash Shah, MD Adam Fano, BS Boris Paskhover, MD Hossein Sadeghi-Nejad, MD |
author_sort | Christopher J. Warren, BA |
collection | DOAJ |
description | Introduction: YouTube is an unregulated platform that patients are using to learn about treatment options. Aim: To assess the reliability of YouTube videos (YTVs) related to male hypogonadism and testosterone therapy. Methods: Searching on YouTube by relevance and view count, we analyzed the top 10 videos (80 videos total) for the following search terms: low testosterone, testosterone replacement therapy, AndroGel, and hypogonadism. Main Outcome Measure: We recorded the number of views for each video, evaluated videos using the DISCERN score (DS) criterion, and compared the DS for videos including board-certified physicians and videos without. A second comparison was made between videos with board-certified physicians in urology, endocrinology, other MD, and those without any physician. Results: The YTVs analyzed received a total of 38,549,090 views, a median of 25,201 and 17.30 views/day. Videos that featured physicians had significantly fewer views/day than videos that did not (39.48 CI 9,72 vs 1,731 CI 330, 3,132; P = .019). Most YTVs studied were unreliable. The median DS across all videos was 2. However, most videos created by physicians were found to be reliable with a median DS of 4. In addition, YTVs that did not feature a physician were found to be significantly less reliable than videos that featured a physician (3.22 CI 3.06, 4.09 vs 1.87 CI 1.56, 2.18; P < .001). There was no significant difference in the reliability or viewership of YTVs stratified by physician type. Conclusion: Most YTVs related to male hypogonadism/testosterone therapy were unreliable, but there are reliable YTVs available. Reliable videos usually feature a physician and receive fewer views than unreliable YTVs. Physicians and academic societies should work to provide verified videos to provide patients with reliable information about male hypogonadism and testosterone therapy.CJ Warren, J Wisener, B Ward, et al. YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy. Sex Med 2021;9:100324. |
first_indexed | 2024-03-12T19:09:35Z |
format | Article |
id | doaj.art-dbaa2a873d664641aff62093f2cf42f9 |
institution | Directory Open Access Journal |
issn | 2050-1161 |
language | English |
last_indexed | 2024-03-12T19:09:35Z |
publishDate | 2021-04-01 |
publisher | Oxford University Press |
record_format | Article |
series | Sexual Medicine |
spelling | doaj.art-dbaa2a873d664641aff62093f2cf42f92023-08-02T06:02:14ZengOxford University PressSexual Medicine2050-11612021-04-0192100324YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone TherapyChristopher J. Warren, BA0John Wisener, BS1Brittany Ward, BS2Sara Behbahani, MS3Tejash Shah, MD4Adam Fano, BS5Boris Paskhover, MD6Hossein Sadeghi-Nejad, MD7Division of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USADivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USADivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USADivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USADivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USADivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USADepartment of Otolaryngology, Rutgers-New Jersey Medical School, Newark NJ, USADivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USA; Department of Urology, Hackensack UMC-Meridian Health, Hackensack NJ, USA; Corresponding Author: Hossein Sadeghi-Nejad, MD, Rutgers New Jersey Medical School, Hackensack Meridian School of Medicine. Tel: 201-342-8977; Fax: 201-342-0623Introduction: YouTube is an unregulated platform that patients are using to learn about treatment options. Aim: To assess the reliability of YouTube videos (YTVs) related to male hypogonadism and testosterone therapy. Methods: Searching on YouTube by relevance and view count, we analyzed the top 10 videos (80 videos total) for the following search terms: low testosterone, testosterone replacement therapy, AndroGel, and hypogonadism. Main Outcome Measure: We recorded the number of views for each video, evaluated videos using the DISCERN score (DS) criterion, and compared the DS for videos including board-certified physicians and videos without. A second comparison was made between videos with board-certified physicians in urology, endocrinology, other MD, and those without any physician. Results: The YTVs analyzed received a total of 38,549,090 views, a median of 25,201 and 17.30 views/day. Videos that featured physicians had significantly fewer views/day than videos that did not (39.48 CI 9,72 vs 1,731 CI 330, 3,132; P = .019). Most YTVs studied were unreliable. The median DS across all videos was 2. However, most videos created by physicians were found to be reliable with a median DS of 4. In addition, YTVs that did not feature a physician were found to be significantly less reliable than videos that featured a physician (3.22 CI 3.06, 4.09 vs 1.87 CI 1.56, 2.18; P < .001). There was no significant difference in the reliability or viewership of YTVs stratified by physician type. Conclusion: Most YTVs related to male hypogonadism/testosterone therapy were unreliable, but there are reliable YTVs available. Reliable videos usually feature a physician and receive fewer views than unreliable YTVs. Physicians and academic societies should work to provide verified videos to provide patients with reliable information about male hypogonadism and testosterone therapy.CJ Warren, J Wisener, B Ward, et al. YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy. Sex Med 2021;9:100324.http://www.sciencedirect.com/science/article/pii/S2050116121000040YouTubeSocial MediaMale HypogonadismTestosterone Therapy |
spellingShingle | Christopher J. Warren, BA John Wisener, BS Brittany Ward, BS Sara Behbahani, MS Tejash Shah, MD Adam Fano, BS Boris Paskhover, MD Hossein Sadeghi-Nejad, MD YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy Sexual Medicine YouTube Social Media Male Hypogonadism Testosterone Therapy |
title | YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy |
title_full | YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy |
title_fullStr | YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy |
title_full_unstemmed | YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy |
title_short | YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy |
title_sort | youtube as a patient education resource for male hypogonadism and testosterone therapy |
topic | YouTube Social Media Male Hypogonadism Testosterone Therapy |
url | http://www.sciencedirect.com/science/article/pii/S2050116121000040 |
work_keys_str_mv | AT christopherjwarrenba youtubeasapatienteducationresourceformalehypogonadismandtestosteronetherapy AT johnwisenerbs youtubeasapatienteducationresourceformalehypogonadismandtestosteronetherapy AT brittanywardbs youtubeasapatienteducationresourceformalehypogonadismandtestosteronetherapy AT sarabehbahanims youtubeasapatienteducationresourceformalehypogonadismandtestosteronetherapy AT tejashshahmd youtubeasapatienteducationresourceformalehypogonadismandtestosteronetherapy AT adamfanobs youtubeasapatienteducationresourceformalehypogonadismandtestosteronetherapy AT borispaskhovermd youtubeasapatienteducationresourceformalehypogonadismandtestosteronetherapy AT hosseinsadeghinejadmd youtubeasapatienteducationresourceformalehypogonadismandtestosteronetherapy |